Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes.
Rachel WongRohith VaddavalliMargaret A HallMonil V PatelCarolyn T BramanteElena CasarighiSteven G JohnsonVeena LingamJoshua D MillerJane ReuschMary SaltzTil StürmerJena S TronieriKenneth J WilkinsJohn B BuseJoel SaltzJared D HulingRichard Moffittnull nullPublished in: Diabetes care (2022)
In a multicenter cohort of patients in the U.S. with preexisting T2D, there was no significant change in longer-term average HbA1c or weight among patients who had COVID-19. Mechanical ventilation was associated with a decrease in HbA1c after COVID-19.
Keyphrases
- mechanical ventilation
- glycemic control
- coronavirus disease
- sars cov
- weight loss
- type diabetes
- body mass index
- preterm infants
- end stage renal disease
- acute respiratory distress syndrome
- physical activity
- ejection fraction
- intensive care unit
- respiratory syndrome coronavirus
- weight gain
- prognostic factors
- blood glucose
- clinical trial
- respiratory failure
- body weight
- skeletal muscle
- insulin resistance